Repair
Siroskin Sirolimus Cream
Sirolimus 0.1%
Siroskin is a topical formulation delivering stabilised 0.1% sirolimus (rapamycin). Working through the mTOR pathway, it is used under professional guidance to help calm and improve the appearance of specific vascular and proliferative skin conditions with regular, measured application. Also it is used in KPRF and angiofibromas treatment.
Indications
- Facial angiofibroma , keratosis pilaris rubra faceii(KPRF) and vascular lesions
- Localised inflammatory skin concerns
- Professional-directed maintenance care
How to use
Apply a thin layer to the affected area once or twice daily on clean, dry skin, as directed by a professional. Introduce gradually and monitor tolerance.
Cautions
Prescription-grade formulation for external use only. Use only under professional supervision. Avoid eyes and mucous membranes. Not recommended during pregnancy or breastfeeding.
Scientific basis
Sirolimus Cream Europe: mTOR Inhibitors and the Biology of Slowing Skin Aging
The dermatological landscape is being transformed by targeted mTOR inhibitors. Today, accessing a Sirolimus cream Europe formulation is the gold standard for advanced keratosis pilaris treatment, resolving facial angiofibromas, and reversing cellular skin aging at the molecular level.